In adults with T2D and ASCVD, tirzepatide was noninferior to dulaglutide for a composite CV outcome at a median 4 y.
Where this comes from
- Record sourced from PubMed, PMID 42081805.
- Also identified by DOI 10.7326/ANNALS-26-00991-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP:[Formula: see text] Cardiology:[Formula: see text] Endocrinology:[Formula: see text].
Medical subject headings
- Diabetes Mellitus, Type 2
- Recombinant Fusion Proteins
- Immunoglobulin Fc Fragments
- Glucagon-Like Peptides
- Hypoglycemic Agents
- Cardiovascular Diseases